Funding for this research was provided by:
National Natural Science Foundation of China (81970659)
Taishan Scholars Program of Shandong Province (tsqn201909199)
Received: 30 March 2021
Accepted: 28 July 2021
First Online: 14 August 2021
: Sixty pairs of BC adjacent and normal tissue samples were collected for this study. Data of all individuals was collected following a brief interview, and written informed permission was obtained from each subject. All of the patients were diagnosed as transitional cell carcinomas by three independent pathologists. All the clinical procedures were approved by the ethical committee of The Affiliated Yantai Yuhuangding Hospital of Qingdao University in 2020 (Approval Number: [KY-E-2020-02-08]) and conformed well to the international guidelines.
: All authors consent to publication.
: The authors declared no competing interests in this work.